TA-100

TA-100 handeln
1.333,70 PKT +8,48 PKT +0,64 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.

Analysen zu TA-100-Werten

Datum Rating Analyst
02.11.15 Radware Sector Perform RBC Capital Markets
08.10.15 Radware Outperform Imperial Capital
07.10.15 Radware Buy Needham & Company, LLC
07.10.15 Radware Buy Dougherty & Company LLC
06.10.15 Radware Perform Oppenheimer & Co. Inc.
03.09.15 Gazit-Globe Buy Chardan Capital Markets
14.08.15 Ceragon Networks Buy Needham & Company, LLC
07.08.15 Teva Pharmaceutical Industries Outperform BMO Capital Markets
30.07.15 Nice Systems Outperform FBR Capital
29.07.15 Radware overweight Barclays Capital
29.07.15 Teva Pharmaceutical Industries Outperform RBC Capital Markets
29.07.15 Radware Buy Needham & Company, LLC
29.07.15 Radware Sector Perform RBC Capital Markets
29.07.15 Radware Outperform Imperial Capital
28.07.15 Teva Pharmaceutical Industries Buy Deutsche Bank AG
28.07.15 Teva Pharmaceutical Industries Buy Argus Research Company
27.07.15 Teva Pharmaceutical Industries Buy Maxim Group
27.07.15 Teva Pharmaceutical Industries Buy Standpoint Research
10.06.15 AudioCodes Outperform Northland Capital
12.05.15 Nice Systems Outperform Imperial Capital
08.05.15 Nice Systems Equal weight Barclays Capital
08.05.15 Nice Systems Sector Perform RBC Capital Markets
01.05.15 Radware Buy Needham & Company, LLC
29.04.15 Teva Pharmaceutical Industries Buy Standpoint Research
24.04.15 Teva Pharmaceutical Industries Market Perform BMO Capital Markets
22.04.15 Teva Pharmaceutical Industries Buy Argus Research Company
08.04.15 Teva Pharmaceutical Industries Hold Standpoint Research
07.04.15 Teva Pharmaceutical Industries overweight Barclays Capital
31.03.15 Teva Pharmaceutical Industries Hold Canaccord Adams
31.03.15 Teva Pharmaceutical Industries Outperform Oppenheimer & Co. Inc.
23.03.15 Nice Systems Outperform Oppenheimer & Co. Inc.
12.02.15 Nice Systems Equal weight Barclays Capital
11.02.15 Nice Systems Outperform Imperial Capital
06.02.15 Nice Systems Outperform FBR Capital
29.01.15 Radware Buy Dougherty & Company LLC
16.01.15 Nice Systems Outperform FBR Capital
13.01.15 Radware Outperform RBC Capital Markets
05.01.15 Radware Outperform Oppenheimer & Co. Inc.
22.12.14 Teva Pharmaceutical Industries Buy Maxim Group
25.11.14 Teva Pharmaceutical Industries Buy Argus Research Company